Alnylam Pharmaceuticals Shares Fall as FDA Advisers Weigh Risks and Benefits
Alnylam Pharmaceuticals Inc. (ALNY) shares dropped over 8% in premarket trading on Thursday following the assessment by advisers to the U.S. Food and Drug Administration (FDA) of the company's treatment…